Headlands Technologies LLC Makes New Investment in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Headlands Technologies LLC bought a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 5,562 shares of the biopharmaceutical company’s stock, valued at approximately $133,000. A number of other […]
More Stories
Stonegate Investment Group LLC Cuts Stake in American Electric Power Company, Inc. (NASDAQ:AEP)
Stonegate Investment Group LLC trimmed its position in shares of American Electric Power Company, Inc. (NASDAQ:AEP – Free Report) by...
Stonegate Investment Group LLC Boosts Stock Position in Laboratory Co. of America Holdings (NYSE:LH)
Stonegate Investment Group LLC boosted its position in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by...
ITT (NYSE:ITT) Price Target Raised to $167.00
ITT (NYSE:ITT – Free Report) had its price target raised by Stifel Nicolaus from $157.00 to $167.00 in a report...
Wells Fargo & Company Raises ONE Gas (NYSE:OGS) Price Target to $82.00
ONE Gas (NYSE:OGS – Free Report) had its target price hoisted by Wells Fargo & Company from $80.00 to $82.00...
Evercore ISI Raises J.B. Hunt Transport Services (NASDAQ:JBHT) Price Target to $185.00
J.B. Hunt Transport Services (NASDAQ:JBHT – Free Report) had its price target boosted by Evercore ISI from $183.00 to $185.00...
Acelyrin (NASDAQ:SLRN) Price Target Raised to $15.00
Acelyrin (NASDAQ:SLRN – Free Report) had its price objective lifted by Wells Fargo & Company from $13.00 to $15.00 in...